Printer Friendly

IVAX ANNOUNCES SEMI-ANNUAL DIVIDEND

 MIAMI, Oct. 29 /PRNewswire/ -- IVAX Corporation (AMEX: IVX) announced today that its board of directors declared a regular semi- annual cash dividend at the rate of $0.02 per share, payable on Dec. 1, 1993 to holders of record of its common stock on Nov. 15, 1993.
 IVAX Corporation is a holding company with subsidiaries involved in specialty chemicals, pharmaceuticals and medical diagnostics. IVAX' principal subsidiaries include Baker Norton Pharmaceuticals, Inc., a developer and marketer of unique brand name pharmaceuticals; Norton Healthcare Limited, a leading manufacturer and marketer of generic pharmaceuticals in the United Kingdom, Ireland and other countries; H N Norton & Co, a manufacturer of generic pharmaceuticals in the United States; Goldline Laboratories, Inc., a national marketer of generic prescription and over the counter pharmaceuticals in the United States; Baker Cummins Dermatologicals, Inc., a dermatological products company; Flori Roberts, Inc., a skin care and cosmetics company; Johnson Products Co., Inc., a personal-care products company; DVM Pharmaceuticals Inc., a veterinary products company; Baker Cummins, Inc., a marketer of brand name pharmaceuticals in Canada; Diamedix Corporation, a medical diagnostics company; Delta Biologicals S.r.l., a marketer of medical diagnostic tests and instruments in Italy; and IVAX Industries, Inc., a chemical specialties business.
 -0- 10/29/93
 /CONTACT: Richard C. Pfenniger Jr., senior vice president-legal affairs, IVAX, 305-590-2309/
 (IVX)


CO: IVAX Corporation ST: Florida IN: MTC SU: DIV

AW-SB -- FL007 -- 8668 10/29/93 16:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 29, 1993
Words:236
Previous Article:MCLOUTH STEEL ANNOUNCES APPOINTMENT OF GENERAL SUPERINTENDENT
Next Article:F.F.O. FINANCIAL GROUP, INC. REPORTS THIRD QUARTER AND YEAR TO DATE RESULTS AND TERMINATION OF CAPITAL DIRECTIVE AND WRITTEN AGREEMENT
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters